Skip to main content

Table 1 Demographic and clinical characteristics of subjects (N = 2711)

From: Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

Age (y)

59.6 ± 9.6

Gender

 

 Male

1803 (66.5)

 Female

908 (33.5)

Smoking history

 

 Smoker

1722 (63.5)

 Never

989 (36.5)

Surgical procedure

 

 Segmentectomy

65 (2.4)

 Lobectomy

2254 (83.1)

 Pneumonectomy

373 (13.8)

 Extended

19 (0.7)

Surgical margin status

 

 Positive

130 (4.8)

 Negative

2581 (95.2)

Histology

 

 Squamous

1365 (50.4)

 Adenocarcinoma

924 (34.1)

 Large cell

33 (1.2)

 Adenosquamous

159 (5.9)

 Other

230 (8.5)

T stage

 

 T1/T2

2354 (86.8)

 T3/T4

357 (13.2)

N stage

 

 N0

1544 (57.0)

 N1/N2

1167 (43.0)

AJCC TNM Stage

 

 IA

558 (20.6)

 IB

589 (21.7)

 II A

444 (16.4)

 IIB

229 (8.4)

 III

891 (32.9)

Lymph node stations examined

 

 < 6 group

1040 (38.4)

 ≥ 6 group

1671 (61.6)

Number of lymph nodes removed

 

 < 10

689 (25.4)

 10-20

943 (34.8)

 ≥ 20

1079 (39.8)

Adjuvant chemotherapy

 

 Yes

1333 (49.2)

 No

1378 (50.8)

Radiotherapy

 

 Yes

427 (15.8)

 No

2284 (84.2)

Immunotherapy

 

 Yes

224 (8.3)

 No

2487 (91.7)

  1. Data are presented as mean ± standard deviation (SD) or number (percentage).
  2. *1151 patients were classified into stage I, 669 in stage II, and 891 in stage III.